A novel cell culture model of chondrocyte differentiation during mammalian endochondral ossification.
Endochondral ossification (EO) occurs in the growth plate where chondrocytes pass through discrete stages of proliferation, maturation, hypertrophy, and calcification. We have developed and characterized a novel bovine cell culture model of EO that mirrors these events and will facilitate in vitro studies on factors controlling chondrocyte differentiation. Chondrocytes derived from the epiphyses of long bones of fetal calves were treated with 5-azacytidine (aza-C) for 48 h. Cultures were maintained subsequently without aza-C and harvested at selected time points for analyses of growth and differentiation status. A chondrocytic phenotype associated with an extensive extracellular matrix rich in proteoglycans and collagen types II and VI was observed in aza-C-treated and -untreated cultures. aza-C-treated cultures were characterized by studying the expression of several markers of chondrocyte differentiation. Parathyroid hormone-related protein (PTHrP) and its receptor, both markers of maturation, were expressed at days 5-9. Type X collagen, which is restricted to the stage of hypertrophy, was expressed from day 11 onward. Hypertrophy was confirmed by a 14-fold increase in cell size by day 15 and an increased synthesis of alkaline phosphatase during the hypertrophic period (days 14-28). The addition of PTHrP to aza-C-treated cultures at day 14 led to the down-regulation of type X collagen by 6-fold, showing type X collagen expression is under the control of PTHrP as in vivo. These findings show that aza-C can induce fetal bovine epiphyseal chondrocytes to differentiate in culture in a manner consistent with that which occurs during the EO process in vivo.
Cheung
J O
JO
Wellcome Trust Center for Cell-Matrix Research, School of Biological Sciences, University of Manchester, UK.
Hillarby
M C
MC
Ayad
S
S
Hoyland
J A
JA
Jones
C J
CJ
Denton
J
J
Thomas
J T
JT
Wallis
G A
GA
Grant
M E
ME
D000818:Animals; D001374:Azacitidine / Q000494:pharmacology; D001483:Base Sequence; D001842:Bone and Bones / Q000196:embryology; D002113:Calcification, Physiologic; D002417:Cattle; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology* / Q000187:drug effects; D017931:DNA Primers; D007150:Immunohistochemistry; D008954:Models, Biological; D044162:Parathyroid Hormone-Related Protein; D010641:Phenotype; D011506:Proteins / Q000494:pharmacology
D017931:DNA Primers; D044162:Parathyroid Hormone-Related Protein; D011506:Proteins; D001374:Azacitidine